Adverse effects Reported by investigators 'and' or 'or' participants · patients with tinea cruris and tinea corporis
It is very uncertain whether azoles changes adverse effects Reported by investigators 'and' or 'or' participants compared with moderate‐potent corticosteroid/azole combinations (very low certainty).
1 finding from 1 review
Relapse or recurrence Not assessed · patients with tinea cruris and tinea corporis
1 finding from 1 review
Cure · patients with tinea cruris and tinea corporis
1 finding from 1 review
Duration of treatment until clinical cure Not assessed · patients with tinea cruris and tinea corporis
1 finding from 1 review
Mycological cure · patients with tinea cruris and tinea corporis
Azoles showed no clear difference in mycological cure Negative KOH microscopy and culture. Treatment… compared with benzylamines (low certainty).
1 finding from 1 review
Clinical cure · patients with tinea cruris and tinea corporis
1 finding from 1 review
Adverse effects Reported by investigators 'and' or 'or' participants · patients with tinea cruris and tinea corporis
It is very uncertain whether azoles changes adverse effects Reported by investigators 'and' or 'or' participants compared with benzylamines (very low certainty).
1 finding from 1 review
Recurrence · patients with tinea cruris and tinea corporis
It is very uncertain whether azoles changes relapse or recurrence Evidence of clinical or mycological disease… compared with benzylamines (very low certainty).
1 finding from 1 review
Participant‐judged cure Not assessed · patients with tinea cruris and tinea corporis
1 finding from 1 review
Adverse effects Reported by investigators 'and' or 'or' participants · patients with tinea cruris and tinea corporis
It is very uncertain whether terbinafine 1% cream/gel changes adverse effects Reported by investigators 'and' or 'or' participants compared with placebo cream/gel (very low certainty).
1 finding from 1 review
Duration of treatment until clinical cure Not assessed · patients with tinea cruris and tinea corporis
1 finding from 1 review
Mycological cure · patients with tinea cruris and tinea corporis
1 finding from 1 review
Clinical cure · patients with tinea cruris and tinea corporis
1 finding from 1 review
Adverse effects Reported by investigators 'and' or 'or' participants · patients with tinea cruris and tinea corporis
It is very uncertain whether azoles changes adverse effects Reported by investigators 'and' or 'or' participants compared with placebo (very low certainty).
1 finding from 1 review
Relapse or recurrence Not assessed · patients with tinea cruris and tinea corporis
1 finding from 1 review
Participant‐judged cure Not assessed · patients with tinea cruris and tinea corporis
1 finding from 1 review
Duration of treatment until clinical cure Not assessed · patients with tinea cruris and tinea corporis
1 finding from 1 review
Recurrence · patients with tinea cruris and tinea corporis
1 finding from 1 review
Participant‐judged cure Judgement of treatment as 'good' or 'very good' · patients with tinea cruris and tinea corporis
Terbinafine 1% cream/gel may leads to higher participant‐judged cure Judgement of treatment as 'good' or 'very… compared with placebo cream/gel (low certainty).
1 finding from 1 review
Duration of treatment until clinical cure Not assessed · patients with tinea cruris and tinea corporis
1 finding from 1 review